CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Danielle McCartney - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Danielle McCartney

OPENALEX: A5063573163↗ORCID: 0000-0002-7783-5220↗

Affiliations

Organizations

Io Therapeutics (United States)authorship · US The University of Sydneyauthorship · AU UNSW Sydneyauthorship · AU

Public evidence

7 connected articles

The Effect of Cannabidiol on Subjective Responses to Endurance Exercise: A Randomised Controlled Trial.2024 · Europe PMC Evaluating possible 'next day' impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial.2024 · Europe PMC A cross-sectional survey exploring the knowledge, experiences and attitudes of Australian pharmacists toward medicinal cannabis.2023 · Europe PMC The "Next Day" Effects of Cannabis Use: A Systematic Review.2023 · Europe PMC Orally administered cannabidiol does not produce false-positive tests for Δ<sup>9</sup> -tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000.2022 · Europe PMC Knowledge, experiences, and attitudes of Australian General Practitioners towards medicinal cannabis: a 2021-2022 survey.2022 · PubMed Central Open Access The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence.2022 · PubMed Central Open Access

Registered research

Connected studies

Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug Interactionsnct06192589

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.